Glycosylated cannabinoids in Cannabis sativa and enzyme design to modulate their synthesis
Abstract Cannabinoids are the primary active compounds in Cannabis sativa and hold significant medical potential. However, their high lipophilicity limits…
Abstract Cannabinoids are the primary active compounds in Cannabis sativa and hold significant medical potential. However, their high lipophilicity limits…
Abstract In T-cell acute lymphoblastic leukemia (T-ALL), more than 50% of cases display autoactivation of Notch1 signaling, leading to oncogenic…
Abstract Medical Cannabis and its major cannabinoids (−)-trans-Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are gaining momentum for various medical purposes as…
Abstract In the last decades, growing evidence showed the therapeutic capabilities of Cannabis plants. These capabilities were attributed to the…
Abstract Supplemental Digital Content is Available in the Text. Women are more susceptible to medical cannabis–related adverse effects because of…
Abstract Introduction: Chronic non-cancer pain (CNCP) is one of the most prevalent indications for medical cannabis (MC) treatment globally. In…
Abstract The therapeutic use of medical Cannabis is growing, and so is the need for standardized and therapeutically stable Cannabis…
Abstract Simple Summary: Cannabis is widely used by patients with cancer to help with cancer symptoms and treatment side effects.…
Abstract Background: Medical cannabis (MC) treatment for migraine is practically emerging, although sufficient clinical data are not available for this…
Abstract The therapeutic effect of the Cannabis plant largely depends on the presence and specific ratio of a spectrum of…